Emerging epigenomic landscapes of pancreatic cancer in the era of precision medicine

Gwen Lomberk; Nelson Dusetti; Juan Iovanna; Raul Urrutia

doi:10.1038/s41467-019-11812-7

Nature Communications (Aug 2019)

Emerging epigenomic landscapes of pancreatic cancer in the era of precision medicine

Gwen Lomberk,
Nelson Dusetti,
Juan Iovanna,
Raul Urrutia

Affiliations

Gwen Lomberk: Division of Research, Department of Surgery and the Genomic Sciences and Precision Medicine Center (GSPMC), Medical College of Wisconsin
Nelson Dusetti: Centre de Recherche en Cancérologie de Marseille (CRCM), INSERM U1068, CNRS UMR 7258, Aix-Marseille Université and Institut Paoli-Calmettes, Parc Scientifique et Technologique de Luminy
Juan Iovanna: Centre de Recherche en Cancérologie de Marseille (CRCM), INSERM U1068, CNRS UMR 7258, Aix-Marseille Université and Institut Paoli-Calmettes, Parc Scientifique et Technologique de Luminy
Raul Urrutia: Division of Research, Department of Surgery and the Genomic Sciences and Precision Medicine Center (GSPMC), Medical College of Wisconsin

DOI: https://doi.org/10.1038/s41467-019-11812-7
Journal volume & issue: Vol. 10, no. 1
pp. 1 – 10

Abstract

Read online

In pancreatic cancer, the epigenomic landscape can strongly impact the disease phenotype. Here, the authors discuss recent advances in our understanding of pancreatic cancer epigenomics, and how this knowledge can integrate with precision medicine approaches in this lethal disease.

Published in Nature Communications

ISSN: 2041-1723 (Online)
Publisher: Nature Portfolio
Country of publisher: United Kingdom
LCC subjects: Science
Website: https://www.nature.com/ncomms/

About the journal